Group 1 - Gujia Home achieved a net profit of 1.02 billion yuan in the first half of 2025, a year-on-year increase of 13.89% [1] - Gujia Home's revenue for the first half of 2025 was 9.80 billion yuan, up 10.02% year-on-year [1] - Phoenix Holdings reported a net profit of 11.04 million yuan, successfully turning a profit [1] - Phoenix Holdings' revenue increased by 200.78% year-on-year to 291 million yuan [1] - Zheshang Securities recorded a net profit of 1.15 billion yuan, a year-on-year growth of 46.49% [1] - Zheshang Securities' revenue decreased by 23.66% to 6.11 billion yuan [1] Group 2 - Tianjin Port's net profit was 503 million yuan, a year-on-year decrease of 18.33% [3] - Tianjin Port's revenue for the first half of 2025 was 6.18 billion yuan, an increase of 4.33% year-on-year [3] - Xuantai Pharmaceutical reported a net profit of 45.59 million yuan, down 15.82% year-on-year [5] - Xuantai Pharmaceutical's revenue was 220 million yuan, a slight increase of 0.74% year-on-year [5] Group 3 - Yilida achieved a net profit of 40.03 million yuan, a year-on-year increase of 18.32% [7] - Yilida's revenue for the first half of 2025 was 758 million yuan, up 12.56% year-on-year [7] - Zhongji United reported a net profit of 262 million yuan, a significant year-on-year increase of 86.61% [9] - Zhongji United's revenue was 818 million yuan, a year-on-year growth of 43.52% [9] Group 4 - China Shipbuilding Special Gas reported a net profit of 178 million yuan, a slight decrease of 0.55% year-on-year [10] - China Shipbuilding Special Gas' revenue was 1.04 billion yuan, an increase of 12.60% year-on-year [10] - Xinyuan Intelligent Manufacturing achieved a net profit of 9.79 million yuan, a year-on-year increase of 284.45% [11] - Xinyuan Intelligent Manufacturing's revenue was 329 million yuan, up 388.33% year-on-year [11] Group 5 - Jiudian Pharmaceutical reported a net profit of 291 million yuan, a year-on-year increase of 2.57% [13] - Jiudian Pharmaceutical's revenue was 1.51 billion yuan, a year-on-year growth of 10.67% [13] - Boya Biological reported a net profit of 225 million yuan, down 28.68% year-on-year [15] - Boya Biological's revenue was 1.01 billion yuan, an increase of 12.51% year-on-year [15] Group 6 - True Love Home achieved a net profit of 197 million yuan, a year-on-year increase of 484.48% [17] - True Love Home's revenue was 390 million yuan, up 21.82% year-on-year [17] - Dongfang Electronics reported a net profit of 302 million yuan, a year-on-year increase of 19.65% [19] - Dongfang Electronics' revenue was 3.16 billion yuan, a year-on-year growth of 12.18% [19] Group 7 - Watte Holdings achieved a net profit of 18.41 million yuan, a year-on-year increase of 23.94% [21] - Watte Holdings' revenue was 906 million yuan, up 12.29% year-on-year [21] - Tianqin Equipment reported a net profit of 16.36 million yuan, a year-on-year increase of 2.78% [22] - Tianqin Equipment's revenue was 111 million yuan, a year-on-year growth of 18.42% [22] Group 8 - Yingfeng Environment achieved a net profit of 382 million yuan, a year-on-year increase of 0.43% [24] - Yingfeng Environment's revenue was 6.46 billion yuan, up 3.69% year-on-year [24] - Kexin Machinery reported a net profit of 52.20 million yuan, a year-on-year decrease of 46.18% [26] - Kexin Machinery's revenue was 592 million yuan, down 17.26% year-on-year [26] Group 9 - Tengda Construction reported a net profit of 108 million yuan, a year-on-year decrease of 0.69% [27] - Tengda Construction's revenue was 1.61 billion yuan, down 5.20% year-on-year [27] - Canaan Technology achieved a net profit of 7.35 million yuan, a year-on-year decrease of 38.46% [29] - Canaan Technology's revenue was 560 million yuan, up 1.29% year-on-year [29] Group 10 - Metro Design reported a net profit of 221 million yuan, a year-on-year increase of 6.58% [30] - Metro Design's revenue was 1.32 billion yuan, up 5.31% year-on-year [30] - China Shipbuilding Special Gas plans to use up to 2.9 billion yuan of idle funds for cash management [31] - The company intends to invest in safe, liquid, principal-protected products [31] Group 11 - Jiuchuang Biotechnology received a medical device registration certificate for its lupus anticoagulant detection kit [32] - The product is intended for in vitro qualitative detection of lupus anticoagulant in human plasma [32] - Xinowei's subsidiary received approval for clinical trials of its innovative drug [33] - The drug is a humanized monoclonal antibody intended for treating multiple cancers [33] Group 12 - Dongcheng Pharmaceutical's subsidiary received FDA approval for clinical trials of its targeted radiopharmaceutical [34] - The drug is intended for treating advanced prostate cancer [34] - Shandong Road and Bridge received approval to issue bonds up to 4 billion yuan [35] - The company specializes in road and bridge engineering construction [35] Group 13 - Diou Home plans to invest 500 million yuan to establish a subsidiary focused on generative AI [36] - The investment aims to transform the company into a full-stack industrial intelligent service provider [36] - Dayilong achieved a net profit of 90.87 million yuan, a year-on-year increase of 217.89% [37] - Dayilong's revenue was 957 million yuan, up 57.35% year-on-year [37] Group 14 - Chaohongji reported a net profit of 331 million yuan, a year-on-year increase of 44.34% [38] - Chaohongji's revenue was 4.10 billion yuan, up 19.54% year-on-year [38] - Taiji Group reported a net profit of 139 million yuan, a year-on-year decrease of 71.94% [39] - Taiji Group's revenue was 5.66 billion yuan, down 27.63% year-on-year [39] Group 15 - Suneng Co. reported a net profit of 93.19 million yuan, a year-on-year decrease of 90.13% [41] - Suneng Co.'s revenue was 5.57 billion yuan, down 17.15% year-on-year [41] - Three Gorges Water Conservancy reported a net profit of 47.93 million yuan, a year-on-year decrease of 79.07% [42] - Three Gorges Water Conservancy's revenue was 4.90 billion yuan, down 6.10% year-on-year [42] Group 16 - Furida reported a net profit of 108 million yuan, a year-on-year decrease of 15.16% [44] - Furida's revenue was 1.79 billion yuan, down 7.05% year-on-year [44] - Chenzhou Electric International achieved a net profit of 25.92 million yuan, a year-on-year increase of 29.55% [46] - Chenzhou Electric International's revenue was 1.96 billion yuan, up 1.26% year-on-year [46] Group 17 - Farlantek achieved a net profit of 122 million yuan, a year-on-year increase of 41.05% [47] - Farlantek's revenue was 1.18 billion yuan, up 46.63% year-on-year [47] - Huitai Medical reported a net profit of 425 million yuan, a year-on-year increase of 24.11% [48] - Huitai Medical's revenue was 1.21 billion yuan, up 21.26% year-on-year [48] Group 18 - Dameng Data's director is under investigation for suspected violations [49] - The company's daily operations remain normal [49] - Maiwei Co. reported a net profit of 394 million yuan, a year-on-year decrease of 14.59% [50] - Maiwei Co.'s revenue was 4.21 billion yuan, down 13.48% year-on-year [50] Group 19 - Waiservice Holdings achieved a net profit of 384 million yuan, a year-on-year increase of 5.51% [52] - Waiservice Holdings' revenue was 12.25 billion yuan, up 16.15% year-on-year [52] - Huakang Co. reported a net profit of 134 million yuan, a year-on-year decrease of 3.38% [53] - Huakang Co.'s revenue was 1.87 billion yuan, up 37.32% year-on-year [53] Group 20 - Bluelight Optical achieved a net profit of 103 million yuan, a year-on-year increase of 110.27% [54] - Bluelight Optical's revenue was 577 million yuan, up 52.54% year-on-year [54] - Shunwang Technology reported a net profit of 162 million yuan, a year-on-year increase of 69.22% [55] - Shunwang Technology's revenue was 1.01 billion yuan, up 25.09% year-on-year [55] Group 21 - Anbiping reported a net loss of 12.50 million yuan in the first half of 2025 [56] - Anbiping's revenue was 159 million yuan, down 30.11% year-on-year [56] - Jinhua Co. reported a net profit of 6.20 million yuan, a year-on-year decrease of 34.53% [57] - Jinhua Co.'s revenue was 241 million yuan, down 1.90% year-on-year [57] Group 22 - Xiehe Electronics achieved a net profit of 28.96 million yuan, a year-on-year decrease of 8.31% [59] - Xiehe Electronics' revenue was 451 million yuan, up 12.13% year-on-year [59] - Huguang Co. reported a net profit of 276 million yuan, a year-on-year increase of 8.40% [60] - Huguang Co.'s revenue was 3.63 billion yuan, up 6.20% year-on-year [60]

证券之星消息，8月22日光伏设备板块较上一交易日上涨2.24%，金博股份领涨。当日上证指数报收于3825.76，上涨1.45%。深证成指报收于 12166.06，上涨2.07%。光伏设备板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 688598 | 金博股份 | 32.00 | 10.12% | 20.73万 | 6.45 Z | | 300751 | 迈为股份 | 85.44 | 6.33% | 13.63万 | 11.58亿 | | 300274 | 阳光电源 | 97.86 | 5.81% | 67.68万 | 65.16亿 | | 600732 | 爱旭股份 | 15.50 | 5.37% | 68.23万 | 10.48亿 | | 688503 | 業和材料 | 54.50 | 5.21% | 18.78万 | 10.41亿 | | 688516 | 奥特維 | 40.62 | 4.48% | 12.60万 | 5.07亿 | | 300842 | 帝科股份 | ...

Group 1 - The company has approved a profit distribution plan, proposing a cash dividend of 5 yuan per 10 shares (including tax) to all shareholders, with no bonus shares issued [1] - The company does not require retrospective adjustments or restatements of previous accounting data [2] - There have been no changes in the controlling shareholder or actual controller during the reporting period [3] Group 2 - The company's operating conditions have not undergone significant changes during the reporting period [3]

苏州迈为科技股份有限公司 重大信息内部报告制度 第一章 总 则 第一条 为规范苏州迈为科技股份有限公司（以下简称"本公司"或者"公 司"）的重大信息内部报告工作，保证公司内部重大信息的快速传递、归集和有 效管理，及时、准确、全面、完整地披露信息，维护投资者的合法权益，根据《中 华人民共和国公司法》《中华人民共和国证券法》《上市公司信息披露管理办法》 《深圳证券交易所创业板股票上市规则》（以下简称"《股票上市规则》"）《苏 州迈为科技股份有限公司章程》（以下简称"《公司章程》"）《公司信息披露 事务管理制度》等有关规定，结合本公司实际，制定本制度。 第二条 公司重大信息内部报告制度是指当出现、发生或者即将发生可能对 公司股票及其衍生品种交易价格产生较大影响的情形或者事件时，按照本制度规 定负有报告义务的单位、部门、人员，应当在第一时间将相关信息向公司董事会 和董事会秘书进行报告，并提供相关的文件和资料的制度。 第三条 本制度适用于公司、分公司、子公司及参股公司。本制度所称"报 告义务人"为公司董事、高级管理人员、各部门负责人、各分子公司负责人、公 司派驻各分支机构的董事、监事（如有）和高级管理人员。 第二章 重 ...

Core Viewpoint - The document outlines the securities investment management system of Suzhou Maiwei Technology Co., Ltd., emphasizing the need for legal compliance, risk management, and effective internal controls in securities investments. Group 1: General Provisions - The purpose of the securities investment management system is to regulate the company's securities investments and related information disclosure, enhance management, prevent investment risks, and ensure asset safety [1] - Securities investments include new stock subscriptions, stock repurchases, equity and depositary receipt investments, bond investments, and other recognized investment behaviors [1] Group 2: Investment Principles - The company must adhere to principles of legality, prudence, safety, and effectiveness in securities investments, establishing robust internal control systems to manage investment risks [3] - Investments should be analyzed for feasibility and necessity, with strict adherence to approved investment limits based on the company's risk tolerance [3][4] Group 3: Decision-Making and Approval Authority - Securities investments exceeding 10% of the latest audited net assets and over 10 million RMB require board approval and timely information disclosure [4] - Investments exceeding 50% of the latest audited net assets and over 50 million RMB must also be submitted for shareholder meeting approval [4] Group 4: Management and Risk Control - A securities investment team is established for daily operations, responsible for project research, planning, and ongoing monitoring of investment progress and risks [6] - The finance department and securities affairs office manage funds and accounts related to securities investments, ensuring compliance with regulations [6] Group 5: Information Disclosure - The company must analyze and disclose relevant information regarding securities investments, including purpose, amount, duration, and risk control measures [8] - The board of directors is responsible for tracking the execution and safety of investments, taking immediate action in case of significant losses [8]

Core Viewpoint - The document outlines the management system for entrusted financial management at Suzhou Maiwei Technology Co., Ltd, emphasizing the need for regulatory compliance, risk prevention, and asset security. Group 1: General Principles - The entrusted financial management system aims to regulate the company's financial management practices and ensure asset safety based on various legal frameworks [1][2]. - Entrusted financial management refers to the act of delegating investment and management of assets to professional financial institutions [1]. Group 2: Principles of Entrusted Financial Management - The company must adhere to principles such as "standardized operation, risk prevention, cautious investment, and value preservation" [2]. - Funds used for entrusted financial management must be idle funds and should not affect normal operations or project funding [2]. - Financial products must meet high safety, liquidity, and controllable risk criteria [2]. Group 3: Decision-Making and Approval Authority - If the entrusted financial management amount exceeds 10% of the latest audited net assets and is over 10 million RMB, it requires board approval [3]. - For amounts exceeding 50% of the latest audited net assets and over 50 million RMB, shareholder meeting approval is necessary [3]. Group 4: Management and Risk Control - The finance department is responsible for the execution of entrusted financial management, including risk assessment and tracking of investment safety [4]. - Regular reporting to management and the board is mandated to ensure transparency and accountability [4]. Group 5: Information Disclosure - The company must disclose details of entrusted financial management, including purpose, amount, method, and duration, in compliance with regulatory requirements [6][7]. - Any significant changes or risks associated with the financial products must be promptly reported [8]. Group 6: Confidentiality and Compliance - Employees involved in entrusted financial management must maintain confidentiality and comply with relevant laws and regulations [18]. - Violations of laws or internal regulations may lead to accountability for responsible personnel [18]. Group 7: Miscellaneous Provisions - The document allows for amendments based on future legal changes and clarifies that the board holds the interpretation rights of the system [19][20].

Core Points - The document outlines the management system for Suzhou Maiwei Technology Co., Ltd, focusing on the role, qualifications, responsibilities, and procedures related to the General Manager [1][2][3] Group 1: General Manager's Role and Structure - The company has one General Manager appointed by the Board of Directors, who is responsible for daily operations and management [1] - The General Manager can propose the appointment or dismissal of several Vice General Managers and a Chief Financial Officer [1][3] - The General Manager is accountable to the Board of Directors and must adhere to laws and company regulations [1][5] Group 2: Qualifications and Disqualifications - The General Manager must possess extensive economic and management knowledge, practical experience, and strong management capabilities [2] - Specific disqualifications for the General Manager include criminal convictions related to corruption, bankruptcy responsibilities, and being a public servant [2][3] Group 3: Responsibilities and Authority - The General Manager is responsible for implementing the Board's decisions, managing daily operations, and ensuring the safety and value of company assets [4][5] - The General Manager has the authority to organize the company's annual plans, propose internal management structures, and appoint or dismiss management personnel [4][10] Group 4: Reporting and Meetings - The General Manager must regularly report to the Board on significant operational matters and is required to hold regular meetings to discuss major issues [12][15] - Decisions made in the General Manager's meetings must be documented and reported to the Board within five working days [9][26] Group 5: Evaluation and Accountability - The Board is responsible for determining the General Manager's compensation and performance evaluation [31] - The General Manager is liable for any violations of laws or company regulations during their tenure [13]

Core Points - The document outlines the information disclosure deferral and exemption system for Suzhou Maiwei Technology Co., Ltd, ensuring compliance with relevant laws and regulations to protect investors' rights [1][2][3] - The company must adhere to the Shenzhen Stock Exchange's rules regarding the deferral and exemption of information disclosure, and it is subject to post-regulation by the exchange [3][4] - Information disclosure obligations must be fulfilled accurately and timely, without misuse of deferral or exemption to mislead investors or engage in illegal activities [4][5] Information Disclosure Deferral and Exemption Conditions - The company can defer or exempt disclosure if the information involves state secrets or could violate confidentiality regulations [5][6] - Commercial secrets can also be deferred or exempted if disclosure could lead to unfair competition or harm the interests of the company or others [6][7] - If the reasons for deferral or exemption are resolved, or if the information becomes difficult to keep confidential, timely disclosure is required [7][8] Internal Management Procedures - The company must carefully determine the conditions for deferral or exemption and prevent unauthorized disclosure of such information [8][9] - Applications for deferral or exemption must be submitted to the board office, and the authenticity of the submitted materials is the responsibility of the relevant department or subsidiary [9][10] - A registration system is established to document the details of deferral or exemption, including the type of information and internal review procedures [10][11] Accountability and Compliance - The company has established a responsibility accountability mechanism for improper deferral or exemption of information disclosure, with potential consequences for responsible personnel [11][12] - All actions must comply with the latest laws, regulations, and the company's articles of association [12][13] - The board of directors is responsible for interpreting and revising the system, which takes effect upon approval [13][14]

苏州迈为科技股份有限公司 信息披露管理制度 第一章 总则 第一条 为规范苏州迈为科技股份有限公司（以下简称"公司"）的信息披 露行为，加强信息披露事务管理，保护投资者合法权益，根据《中华人民共和国 公司法》（以下简称"《公司法》"）《中华人民共和国证券法》（以下简称"《证 券法》"）《上市公司信息披露管理办法》《深圳证券交易所创业板股票上市规 则》（以下简称"《股票上市规则》"）等法律、法规及《苏州迈为科技股份有 限公司章程》（以下简称"《公司章程》"）的有关规定，制定本制度。 第二条 本制度所称信息披露是指达到证券监管部门关于公司信息披露的标 准要求，根据相关法律、法规、部门规章及证券监管部门的规范性文件，将可能 对公司股票及衍生品种价格产生较大影响而投资者尚未得知的重大信息，在规定 时间内，通过规定的媒体，以规定的方式向社会公众公布，并在证券监管部门备 案。 第三条 本制度所指信息是指可能对公司证券及其衍生品种交易价格或者对 投资者作出价值判断和投资决策产生较大影响的信息或者事项及证券监管机构 要求披露的其他信息。 第四条 公司的信息披露义务人包括但不限于： （一）公司及公司董事、高级管理人员； （二）公 ...

关联交易管理制度 第一章 总 则 第一条 为进一步加强苏州迈为科技股份有限公司（以下简称"本公司"或"公 司"）关联交易管理，明确管理职责和分工，维护公司股东和债权人的合法利益， 特别是中小投资者的合法利益，保证公司与关联方之间订立的关联交易合同符合 公平、公正、公开的原则，依据《公司法》《深圳证券交易所创业板股票上市规 则》（以下简称"《股票上市规则》"）《苏州迈为科技股份有限公司章程》（以 下简称"《公司章程》"）以及其它有关法律、法规、规章的规定，制定本制度。 第二条 本制度所称关联交易，是指公司或者全资子公司、控股子公司与公司 关联人之间发生的转移资源或者义务的事项，包括以下交易： （一）购买或者出售资产； （二）对外投资（含委托理财、对子公司投资等，设立或者增资全资子公司 除外）； （十一）放弃权利（含放弃优先购买权、优先认缴出资权利等）； 上述第（一）项所指购买或者出售资产，不包括购买原材料、燃料和动力， 以及出售产品或者商品等与日常经营相关的交易行为。 第三条 公司的关联人包括关联法人和关联自然人。 苏州迈为科技股份有限公司 （一）具有以下情形之一的法人或者其他组织，为公司的关联法人： 者其他组 ...